CSL Limited is a global biotechnology company that operates in the Human Health, JRH Biosciences, Animal Health, and ZLB Plasma Services sectors. The company develops, manufactures, and markets pharmaceutical products of biological origin, including life-saving medicines for disorders such as haemophilia and primary immune deficiencies, and vaccines to prevent influenza. CSL is committed to innovation and has a team of over 1,100 scientists dedicated to solving patients' unmet needs. The company collaborates with patient and medical communities to improve access to therapies, advance scientific knowledge, and support future medical researchers. With over 32,000 employees worldwide, CSL has earned a reputation as a responsible organization driven to care for patients and deliver on its commitments.